Sanders Morris Harris’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-11,100
Closed -$30.4K 137
2026
Q1
$30.4K Buy
+11,100
New +$35.1K ﹤0.01% 290
2025
Q4
Sell
-20,073
Closed -$53.2K 120
2025
Q3
$53.2K Buy
+20,073
New +$38.8K 0.01% 295
2025
Q2
Sell
-20,073
Closed -$28.6K 210
2025
Q1
$28.6K Buy
20,073
+8,973
+81% +$16.5K ﹤0.01% 278
2024
Q4
$24.4K Buy
+11,100
New +$25.9K ﹤0.01% 283
2022
Q4
Sell
-12,200
Closed -$80K 224
2022
Q3
$80K Hold
12,200
0.02% 277
2022
Q2
$79K Sell
12,200
-12,200
-50% -$69.2K 0.02% 276
2022
Q1
$113K Buy
24,400
+12,200
+100% +$52.3K 0.02% 286
2021
Q4
$63K Hold
12,200
0.01% 302
2021
Q3
$125K Hold
12,200
0.02% 297
2021
Q2
$242K Hold
12,200
0.05% 267
2021
Q1
$336K Hold
12,200
0.07% 208
2020
Q4
$328K Buy
+12,200
New +$365K 0.07% 216

Other funds holding ESPR